Theranautilus, a pioneering deep-tech company specializing in nanorobotic solutions for healthcare, has raised $1.2 million in a seed funding round led by pi Ventures. Additional backing came from Golden Sparrow Ventures and prominent angel investors, including Abhishek Goyal, founder and CEO of Tracxn, and Lalit Keshre, CEO of Groww.
The funding will support the commercialization of nanorobotics-based medical devices, with an initial focus on dental care applications. Theranautilus plans to use the investment to refine its go-to-market strategy and explore broader applications of its technology beyond dental treatments.
Founded in 2020 by Ambarish Ghosh, Debayan Dasgupta, and Peddi Shanmukh Srinivas, Theranautilus addresses critical challenges in dental health using advanced nanorobotic systems. One of its key innovations targets dental hypersensitivity, a condition affecting over 2 billion people globally and estimated to be a $6 billion market.
Theranautilus employs precision-engineered nanorobots to deliver biocompatible materials directly to damaged dental tissues. These materials can be externally activated to form bio-mimetic structures, enabling effective tissue repair and providing long-term relief.
With its internationally patented technology, Theranautilus also aims to expand into cancer therapy and other critical healthcare applications, leveraging its nanorobotics platform to develop cutting-edge theranostic interventions.